Cargando…

Ferroptosis: A new therapeutic target for bladder cancer

Bladder cancer (BC) is the most frequent type of urinary system cancer. The prognosis of BC is poor due to high metastasis rates and multidrug resistance. Hence, development of novel therapies targeting BC cell death is urgently needed. As a novel cell death type with strong antitumor potential, fer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Fan, Lan, Yunping, Wang, Ning, Huang, Xiaobo, Zhou, Qiao, Wang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669411/ https://www.ncbi.nlm.nih.gov/pubmed/36408230 http://dx.doi.org/10.3389/fphar.2022.1043283

Ejemplares similares

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)

GLP-1 Receptor: A New Target for Sepsis
por: Yang, Fuxun, et al.
Publicado: (2021)

Ferroptosis plays a novel role in nonalcoholic steatohepatitis pathogenesis
por: Xiong, Fei, et al.
Publicado: (2022)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke
por: Wei, Ziqing, et al.
Publicado: (2022)

Targeting ferroptosis as novel therapeutic approaches for epilepsy
por: Jin, Yuzi, et al.
Publicado: (2023)

Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential
por: Xu, Chuchu, et al.
Publicado: (2023)

Ferroptosis as an emerging therapeutic target in liver diseases
por: Lu, Yuzhen, et al.
Publicado: (2023)

Ferroptosis as a therapeutic target for inflammation-related intestinal diseases
por: Zhang, Xiaoli, et al.
Publicado: (2023)

Network Pharmacology Identifies Therapeutic Targets and the Mechanisms of Glutathione Action in Ferroptosis Occurring in Oral Cancer
por: Huang, Chen, et al.
Publicado: (2022)

Induction mechanism of ferroptosis: A novel therapeutic target in lung disease
por: Pan, Lingyu, et al.
Publicado: (2022)

The therapeutic potential of natural products for treating pancreatic cancer
por: He, Xia, et al.
Publicado: (2022)

Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
por: Sun, Huiyan, et al.
Publicado: (2023)

Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
por: Li, Le, et al.
Publicado: (2023)

Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials
por: Feng, Qi, et al.
Publicado: (2022)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Ferroptosis as a promising therapeutic strategy for melanoma
por: Ta, Na, et al.
Publicado: (2023)

Resveratrol: Potential Application in Sepsis
por: Li, Jiajia, et al.
Publicado: (2022)

Targeting ferroptosis, the achilles’ heel of breast cancer: A review
por: Liu, Yang, et al.
Publicado: (2022)

Ferroptosis: A new insight for treatment of acute kidney injury
por: Li, Shiyang, et al.
Publicado: (2022)

Ferritinophagy, a form of autophagic ferroptosis: New insights into cancer treatment
por: Sun, Kai, et al.
Publicado: (2022)

Baicalin Inhibits Ferroptosis in Intracerebral Hemorrhage
por: Duan, Lining, et al.
Publicado: (2021)

Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach
por: Zhou, Qiao, et al.
Publicado: (2022)

Functional Nanomedicines for Targeted Therapy of Bladder Cancer
por: Tang, Chao, et al.
Publicado: (2021)

Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer
por: Lu, Ling, et al.
Publicado: (2022)

Natural Product Erianin Inhibits Bladder Cancer Cell Growth by Inducing Ferroptosis via NRF2 Inactivation
por: Xiang, Yu, et al.
Publicado: (2021)

Iron dyshomeostasis and ferroptosis in Alzheimer’s disease: Molecular mechanisms of cell death and novel therapeutic drugs and targets for AD
por: Zhang, Yuan, et al.
Publicado: (2022)

The Role of Ferroptosis in Cancer Development and Treatment Response
por: Lu, Bin, et al.
Publicado: (2018)

Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
por: Liu, Xuan, et al.
Publicado: (2022)

Ferroptosis, a New Insight Into Acute Lung Injury
por: Yin, Xiaofang, et al.
Publicado: (2021)

Ferroptosis-Inducing Nanomedicine for Cancer Therapy
por: Wang, Yang, et al.
Publicado: (2021)

Bilirubin Protects Transplanted Islets by Targeting Ferroptosis
por: Yao, Qing, et al.
Publicado: (2020)

Necroptosis in Pulmonary Diseases: A New Therapeutic Target
por: Wang, Lingling, et al.
Publicado: (2021)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapy
por: Shi, Jing-Fen, et al.
Publicado: (2023)

Dihydroquercetin Attenuates Silica-Induced Pulmonary Fibrosis by Inhibiting Ferroptosis Signaling Pathway
por: Yuan, Leyong, et al.
Publicado: (2022)

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
por: Qin, Lu-Yun, et al.
Publicado: (2022)

Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
por: Yuan, Suxin, et al.
Publicado: (2022)

Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy
por: Zhang, Le, et al.
Publicado: (2022)

The Art of War: Ferroptosis and Pancreatic Cancer
por: Liu, Jiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kb1stbm6fccrof7vphj8ocejr6